Market research
ZOTA.NSE Zota Health Care Limited
NSE INR Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 33B
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- 0.0%
- Beta
- 0.38
Profile
Company facts
- Exchange
- NSE
- Currency
- INR
- Sector
- Healthcare
- Industry
- Biotechnology
- ISIN
- INE358U01012
- Market cap
- 33B
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- 0.0%
- Beta
- 0.38
About
About Zota Health Care Limited
Zota Health Care Limited develops, manufactures, and markets pharmaceutical products in India and internationally. The company offers generic drugs, health supplements, over-the-counter products, wellness and ayurvedic products, and nutraceutical products. It provides various medicines for chronic ailments, such as diabetes, cardiac, and thyroid disorders. The company operates its retail stores under the DAVAINDIA name. Zota Health Care Limited was founded in 1995 and is headquartered in Surat, India.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the ZOTA.NSE discussion.
5 years, 5 months ago
Zota Health Care Limited is currently in a long term uptrend where the price is trading 49.6% above its 200 day moving average.
From a valuation standpoint, the stock is 20.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.8.
Zota Health Care Limited's total revenue rose by 21.6% to $305M since the same quarter in the previous year.
Its net income has dropped by 365.1% to $-10M since the same quarter in the previous year.
Finally, its free cash flow fell by 124.8% to $-5M since the same quarter in the previous year.
Based on the above factors, Zota Health Care Limited gets an overall score of 3/5.